IDEXX Laboratories Announces New App that Enables Real-time Results Notification for Android™ Users
Veterinarians can now stay up-to-the-minute with every case and inform pet owners more quickly about the health and well-being of their pet
WESTBROOK, Maine, September 25, 2014 — IDEXX Laboratories, Inc. (NASDAQ: IDXX) today announced the availability of the IDEXX VetConnect® PLUS mobile app for Android™ devices. The VetConnect® PLUS mobile app was introduced to iPhone® users earlier this year. The new Android app further supports the company’s Strengthen the bonds™ initiative, which is designed to help veterinarians deliver exceptional care to pets while sustaining a healthy practice.
With the addition of Android devices now being supported by the VetConnect PLUS mobile app, more than 90 percent of IDEXX customers with smartphones have immediate, convenient access to diagnostic results. Both the Android and iPhone mobile apps provide veterinarians with notifications on their mobile device the moment diagnostic results are ready, including those generated from IDEXX in-house analyzers, SNAP® tests and IDEXX Reference Laboratories. As a result, veterinarians are able to make clinical decisions in real time, enabling them to address patient health and client concerns as quickly as possible.
“The ability to view diagnostic results the moment they are ready has a significant impact on our customers’ ability to provide timely patient care and make important medical decisions, especially in critical health situations,” said Jonathan Ayers, president and chief executive officer, IDEXX Laboratories, Inc. “With both iPhone and Android users now able to access the VetConnect PLUS mobile app, the convenience and benefits of mobile health may truly be realized by the veterinary industry.”
“With the VetConnect PLUS mobile app, I now have the flexibility to monitor patient health outside the practice,” said Dr. Julie Dudak, owner, Veterinary Hospital of Oak Ridge. “With immediate results on my phone, I can let my team know next steps for additional diagnostics or treatment when I’m not in the office.”
The new Android app allows veterinarians to quickly and easily access complete diagnostic information anytime, from any location. Familiar Android pop-up alerts, banners, icon badges, sounds or vibrations signal the availability of new results. Background synchronizing ensures that quantitative and qualitative results—including reference intervals, comments and run notes—are always current. Read/Unread status works in synch with the cloud, enabling veterinarians to track new results across the VetConnect PLUS website and mobile devices. The ability to create custom views allows veterinarians to filter results in order to view only the cases they are monitoring at any given time.
“IDEXX is committed to providing veterinarians with technologies that advance pet health and help practices succeed,” said Ayers. “We are thrilled with global customer enthusiasm and response to VetConnect PLUS and the mobile solution. We have 14,600 worldwide activations of VetConnect PLUS as of the end of June 2014, across 15 countries.”
The VetConnect PLUS app may be downloaded from the Google Play or Apple App store. To activate IDEXX VetConnect PLUS, visit idexx.com/vetconnectplus or idexx.ca/vetconnectplus.
About IDEXX Laboratories
IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. IDEXX is also a worldwide leader in providing livestock and poultry diagnostic tests and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 6,000 people and offers products to customers in more than 175 countries.
Note Regarding Forward-Looking Statements
This trade release contains or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as “expects,” “may,” “anticipates,” “intends,” “would,” “will,” “plans,” “believes,” “estimates,” “should,” and similar words and expressions. These forward-looking statements are based on management's current expectations and beliefs, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by the Company pursuant to United States securities laws contain discussions of these risks and uncertainties. The Company assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers are advised to review the Company's filings with the United States Securities and Exchange Commission (which are available from the SEC’s EDGAR database at www.sec.gov, at various SEC reference facilities in the United States and via the Company’s website at www.idexx.com).
Contact
IDEXX Laboratories, Inc.
Sara Stone
Marketing Manager
1-207-556-8127